2017年

1. Yoshihisa A, Sato T, Kajimoto K, Sato N and Takeishi Y. Heterogeneous impact of body mass index on in-hospital mortality in acute heart failure syndromes: An analysis from the ATTEND Registry. European heart journal Acute cardiovascular care. 2017:2048872617703061.
2. Sato N, Lam CS, Teerlink JR, Greenberg BH, Tsutsui H, Oh BH, Zhang J, Lefkowitz M, Hua TA, Holbro T, Marshood M, Wang XL and Ge J. Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial. Journal of cardiac failure. 2017; 23: 63-71.
3. Minami Y, Kajimoto K, Sato N, Hagiwara N and Takano T. C-reactive protein level on admission and time to and cause of death in patients hospitalized for acute heart failure. European heart journal Quality of care & clinical outcomes. 2017; 3: 148-156.
4. Kinugawa K, Inomata T, Sato N, Yasuda M, Shimakawa T, Bando K and Fukuta Y. Who Needs Longer Tolvaptan Treatment? International heart journal. 2017; 58: 30-35.
5. Kajimoto K, Minami Y, Sato N, Otsubo S and Kasanuki H. Gender Differences in Left Ventricular Ejection Fraction and Outcomes Among Patients Hospitalized for Acute Decompensated Heart Failure. The American journal of cardiology. 2017; 119: 1623-1630.
6. Kajimoto K, Minami Y, Sato N, Otsubo S and Kasanuki H. Gender Differences in Anemia and Survival in Patients Hospitalized for Acute Decompensated Heart Failure With Preserved or Reduced Ejection Fraction. The American journal of cardiology. 2017; 120: 435-442.
7. Kajimoto K, Minami Y, Otsubo S and Sato N. Association of admission and discharge anemia status with outcomes in patients hospitalized for acute decompensated heart failure: Differences between patients with preserved and reduced ejection fraction. European heart journal Acute cardiovascular care. 2017:2048872617730039.
8. Kajimoto K, Minami Y, Otsubo S and Sato N. Ischemic or Nonischemic Functional Mitral Regurgitation and Outcomes in Patients With Acute Decompensated Heart Failure With Preserved or Reduced Ejection Fraction. The American journal of cardiology. 2017.
9. Inomata T, Ikeda Y, Kida K, Shibagaki Y, Sato N, Kumagai Y, Shinagawa H, Ako J and Izumi T. Effects of additive tolvaptan versus increased furosemide on heart failure with diuretic resistance and renal impairment: Results from the K-STAR study. Circulation Journal. 2017.
10. Hatori Y, Sakai H, Kunishima T, Hatori N, Chen L, Ishigami T and Satoh N. Rationale and design of ASSAF-K (A study of the safety and efficacy of anticoagulant therapy in the treatment of atrial fibrillation in Kanagawa). Journal of arrhythmia. 2017; 33: 111-116.
11. Gayat E, Arrigo M, Littnerova S, Sato N, Parenica J, Ishihara S, Spinar J, Muller C, Harjola VP, Lassus J, Miro O, Maggioni AP, AlHabib KF, Choi DJ, Park JJ, Zhang Y, Zhang J, Januzzi JL, Jr., Kajimoto K, Cohen-Solal A and Mebazaa A. Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched study. European journal of heart failure. 2017.
12. Asano R, Kajimoto K, Oka T, Sugiura R, Okada H, Kamishima K, Hirata T and Sato N. Association of New York Heart Association functional class IV symptoms at admission and clinical features with outcomes in patients hospitalized for acute heart failure syndromes. International journal of cardiology. 2017; 230: 585-591.
13. Arrigo M, Gayat E, Parenica J, Ishihara S, Zhang J, Choi DJ, Park JJ, Alhabib KF, Sato N, Miro O, Maggioni AP, Zhang Y, Spinar J, Cohen-Solal A, Iwashyna TJ and Mebazaa A. Precipitating factors and 90-day outcome of acute heart failure: a report from the intercontinental GREAT registry. European journal of heart failure. 2017; 19: 201-208.

2016年

1. Vaduganathan M, Marti CN, Mentz RJ, Greene SJ, Ambrosy AP, Subacius HP, Fonarow GC, Chioncel O, Bazari H, Maggioni AP, Zannad F, Konstam MA, Sato N, Gheorghiade M and Butler J. Serum Osmolality and Postdischarge Outcomes After Hospitalization for Heart Failure. The American journal of cardiology. 2016; 117: 1144-50.
2. Shiraishi Y, Kohsaka S, Harada K, Miyamoto T, Tanimoto S, Iida K, Sakai T, Miyazaki T, Yagawa M, Matsushita K, Furihata S, Sato N, Fukuda K, Yamamoto T, Nagao K and Takayama M. Correlation of Pre- and In-Hospital Systolic Blood Pressure in Acute Heart Failure Patients and the Prognostic Implications- Report From the Tokyo Cardiac Care Unit Network Emergency Medical Service Database. Circulation journal : official journal of the Japanese Circulation Society. 2016; 80: 2473-2481.
3. Sato N, Ajioka M, Yamada T, Kato M, Myoishi M, Yamada T, Kim SY, Nowack C, Kolkhof P and Shiga T. A Randomized Controlled Study of Finerenone vs. Eplerenone in Japanese Patients With Worsening Chronic Heart Failure and Diabetes and/or Chronic Kidney Disease. Circulation journal : official journal of the Japanese Circulation Society. 2016; 80: 1113-22.
4. Mizuno M, Kajimoto K, Sato N, Yumino D, Minami Y, Murai K, Munakata R, Asai K, Keida T, Sakata Y, Hagiwara N and Takano T. Clinical profile, management, and mortality in very-elderly patients hospitalized with acute decompensated heart failure: An analysis from the ATTEND registry. European journal of internal medicine. 2016; 27: 80-5.
5. Minami Y, Kajimoto K, Sato N, Hagiwara N, Takano T and Mebazaa A. Heterogeneity of the prognostic significance of B-type natriuretic peptide levels on admission in patients hospitalized for acute heart failure syndromes. European journal of internal medicine. 2016; 31: 41-9.
6. Minami Y, Kajimoto K, Sato N, Hagiwara N and Takano T. End-stage renal disease patients on chronic maintenance hemodialysis in a hospitalized acute heart failure cohort: Prevalence, clinical characteristics, therapeutic options, and mortality. International journal of cardiology. 2016; 224: 267-270.
7. Mentz RJ, Roessig L, Greenberg BH, Sato N, Shinagawa K, Yeo D, Kwok BW, Reyes EB, Krum H, Pieske B, Greene SJ, Ambrosy AP, Kelly JP, Zannad F, Pitt B and Lam CS. Heart Failure Clinical Trials in East and Southeast Asia: Understanding the Importance and Defining the Next Steps. JACC Heart failure. 2016; 4: 419-27.
8. Mebazaa A, Tolppanen H, Mueller C, Lassus J, DiSomma S, Baksyte G, Cecconi M, Choi DJ, Cohen Solal A, Christ M, Masip J, Arrigo M, Nouira S, Ojji D, Peacock F, Richards M, Sato N, Sliwa K, Spinar J, Thiele H, Yilmaz MB and Januzzi J. Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance. Intensive care medicine. 2016; 42: 147-63.
9. Kajimoto K, Sato N and Takano T. Association of anemia and renal dysfunction with in-hospital mortality among patients hospitalized for acute heart failure syndromes with preserved or reduced ejection fraction. European heart journal Acute cardiovascular care. 2016; 5: 89-99.
10. Kajimoto K, Sato N and Takano T. eGFR and Outcomes in Patients with Acute Decompensated Heart Failure with or without Elevated BUN. Clinical journal of the American Society of Nephrology : CJASN. 2016; 11: 405-12.
11. Kajimoto K, Sato N and Takano T. Association between age, time after hospitalization, and survival among patients hospitalized for acute heart failure syndromes. International journal of cardiology. 2016; 212: 151-3.
12. Kajimoto K, Sato N and Takano T. Functional mitral regurgitation at discharge and outcomes in patients hospitalized for acute decompensated heart failure with a preserved or reduced ejection fraction. European journal of heart failure. 2016; 18: 1051-9.
13. Kajimoto K, Sato N and Takano T. Relationship of renal insufficiency and clinical features or comorbidities with clinical outcome in patients hospitalised for acute heart failure syndromes. European heart journal Acute cardiovascular care. 2016.
14. Kajimoto K, Minami Y, Sato N and Takano T. Serum sodium concentration, blood urea nitrogen, and outcomes in patients hospitalized for acute decompensated heart failure. International journal of cardiology. 2016; 222: 195-201.
15. Kajimoto K, Minami Y, Sato N and Kasanuki H. Etiology of Heart Failure and Outcomes in Patients Hospitalized for Acute Decompensated Heart Failure With Preserved or Reduced Ejection Fraction. The American journal of cardiology. 2016; 118: 1881-1887.
16. Fukushima Y, Kumita S, Tokita Y and Sato N. Prognostic Value of Myocardial Perfusion SPECT After Intravenous Bolus Administration of Nicorandil in Patients with Acute Ischemic Heart Failure. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2016; 57: 385-91.
17. Akutsu K, Yamanaka H, Katayama M, Yamamoto T, Takayama M, Osaka M, Sato N and Shimizu W. Usefulness of Measuring the Serum Elastin Fragment Level in the Diagnosis of an Acute Aortic Dissection. The American journal of cardiology. 2016; 118: 1405-1409.

2015年

1. Wakabayashi K, Sato N, Kajimoto K, Minami Y, Mizuno M, Keida T, Asai K, Munakata R, Murai K, Sakata Y, Suzuki H and Takano T. Incidence and predictors of in-hospital non-cardiac death in patients with acute heart failure. European heart journal Acute cardiovascular care. 2015.
2. Vaduganathan M, Mentz RJ, Greene SJ, Senni M, Sato N, Nodari S, Butler J and Gheorghiade M. Combination decongestion therapy in hospitalized heart failure: loop diuretics, mineralocorticoid receptor antagonists and vasopressin antagonists. Expert review of cardiovascular therapy. 2015; 13: 799-809.
3. Vaduganathan M, Butler J, Roessig L, Fonarow GC, Greene SJ, Metra M, Cotter G, Kupfer S, Zalewski A, Sato N, Filippatos G and Gheorghiade M. Clinical trials in hospitalized heart failure patients: targeting interventions to optimal phenotypic subpopulations. Heart failure reviews. 2015; 20: 393-400.
4. Teixeira A, Parenica J, Park JJ, Ishihara S, AlHabib KF, Laribi S, Maggioni A, Miro O, Sato N, Kajimoto K, Cohen-Solal A, Fairman E, Lassus J, Mueller C, Peacock WF, Januzzi JL, Jr., Choi DJ, Plaisance P, Spinar J, Mebazaa A and Gayat E. Clinical presentation and outcome by age categories in acute heart failure: results from an international observational cohort. European journal of heart failure. 2015; 17: 1114-23.
5. Shiraishi Y, Kohsaka S, Harada K, Sakai T, Takagi A, Miyamoto T, Iida K, Tanimoto S, Fukuda K, Nagao K, Sato N and Takayama M. Time Interval from Symptom Onset to Hospital Care in Patients with Acute Heart Failure: A Report from the Tokyo Cardiac Care Unit Network Emergency Medical Service Database. PloS one. 2015; 10: e0142017.
6. Sato N, Takahashi W, Hirayama A, Ajioka M, Takahashi N, Okishige K, Wang X, Maki A, Maruyama H, Ebinger U, Yamaguchi M, Pang Y, Matsumoto H and Kawana M. Multicenter, Randomized, Double-Blinded, Placebo-Controlled Phase II Study of Serelaxin in Japanese Patients With Acute Heart Failure. Circulation journal : official journal of the Japanese Circulation Society. 2015; 79: 1237-47.
7. Sato N. Lessons and Perspectives on Heart Failure Management From Considerations Based on the CHART-2 Study. Circulation journal : official journal of the Japanese Circulation Society. 2015; 79: 1689-90.
8. Sato N. Epidemiology of Heart Failure in Asia. Heart failure clinics. 2015; 11: 573-9.
9. Minami Y, Kajimoto K, Sato N, Aokage T, Mizuno M, Asai K, Munakata R, Yumino D, Murai K, Hagiwara N, Mizuno K, Kasanuki H and Takano T. Third heart sound in hospitalised patients with acute heart failure: insights from the ATTEND study. International journal of clinical practice. 2015; 69: 820-8.
10. Mebazaa A, Longrois D, Metra M, Mueller C, Richards AM, Roessig L, Seronde MF, Sato N, Stockbridge NL, Gattis Stough W, Alonso A, Cody RJ, Cook Bruns N, Gheorghiade M, Holzmeister J, Laribi S and Zannad F. Agents with vasodilator properties in acute heart failure: how to design successful trials. European journal of heart failure. 2015; 17: 652-64.
11. Kinugawa K, Inomata T, Sato N, Yasuda M, Shimakawa T, Bando K and Mizuguchi K. Effectiveness and adverse events of tolvaptan in octogenarians with heart failure. Interim analyses of Samsca Post-Marketing Surveillance In Heart faiLurE (SMILE study). International heart journal. 2015; 56: 137-43.
12. Kamiya M, Sato N, Nozaki A, Akiya M, Okazaki H, Takahashi Y, Mizuno K and Shimizu W. Renal effects of added low-dose dopamine in acute heart failure patients with diuretic resistance to natriuretic peptide. Journal of cardiovascular pharmacology. 2015; 65: 282-8.
13. Kajimoto K, Sato N and Takano T. Association between anemia, clinical features and outcome in patients hospitalized for acute heart failure syndromes. European heart journal Acute cardiovascular care. 2015; 4: 568-76.
14. Kajimoto K, Sato N and Takano T. Relation of left ventricular ejection fraction and clinical features or co-morbidities to outcomes among patients hospitalized for acute heart failure syndromes. The American journal of cardiology. 2015; 115: 334-40.
15. Kajimoto K, Sato N and Takano T. Association of age and baseline systolic blood pressure with outcomes in patients hospitalized for acute heart failure syndromes. International journal of cardiology. 2015; 191: 100-6.
16. Kajimoto K, Sato N and Takano T. Relation between elevated blood urea nitrogen, clinical features or comorbidities, and clinical outcome in patients hospitalized for acute heart failure syndromes. International journal of cardiology. 2015; 201: 311-4.

2014年

1. Minami Y, Kajimoto K, Sato N, Aokage T, z Mizuno M, Asai K, Munakata R, Yumino D, Murai K, HagiwaraN, Mizuno K, KasanukiH, Takano T, for the ATTEND Study Investigators. Third heart sound in hospitalized patients with acute heart failure: Insights from the ATTEND study. Int J Clin Prac 2014.
2. Kinugawa K, Inomata T, Sato N, Shimakawa T, Iwatake N, Mizuguchi K. Effectiveness and adverse events of tolvaptan in octogenarians with heart failure. Int Heart J 2014, in press.
3. Kamiya M, Sato N, Nozaki A, Akiya M, Okazaki H, Takahashi Y, Mizuno K, Shimizu W. Renal effects of added low-dose dopamine in acute heart failure patients with diuretic resistance to natriuretic peptide. J Cardiovasc Pharm 2014.
4. Kajimoto K, Sato N, Takano T, on behalf of the investigators of the Acute Decompensated Heart Failure Syndromes (ATTEND) registry. Relation of Left Ventricular Ejection Fraction and Clinical Features or Comorbidities to Outcomes Among Patients Hospitalized for Acute Heart Failure Syndromes. Am J Cardiol 2014.
5. Kajimoto K, Sato N, Takano T; on behalf of the investigators of the Acute Decompensated Heart Failure Syndromes (ATTEND) registry. Association between anemia, clinical features and outcome in patients hospitalized for acute heart failure syndromes. Eur Heart J Acute Cardiovasc Care. 2014.
6. Mizuno M, Sato N, Kajimoto K, Sakata Y, Minami Y, Munakata R, Hagiwara N, Takano T; Acute Decompensated Heart Failure Syndromes [ATTEND] investigators. Intra-aortic balloon counterpulsation for acute decompensated heart failure. Int J Cardiol. 2014 Sep 2.
7. Sato N. Awareness of the vasopressin system in heart failure: Lessons from a novel aquaretic agent. Circ J 78:2157-2158, 2014.
8. Inohara, Kosaka S, Sato N, Kajimoto K, Keida T, Mizuno M, Takano T. Prognostic impact of renal dysfunction does not differ according to the clinical profiles of patients: Insight from the acute decompensated heart failure syndromes (ATTEND) registry. PLOS ONE 2014.
9. Kajimoto K, Sato N, Associations of anemia and renal dysfunction with outcomes among patients and renal dysfunction with outcomes among patients hospitalized for acute decompensated heart failure with preserved or reduced ejection fraction. Clin J Am Soc Nephrol 2014.
10. Tokita Y, Yamamoto T, Sato N, Hosokawa Y, Munakata R, Akutsu K, Shimizu W, Tanaka K. Usefulness of N-terminal pro-brain natriuretic peptide levels to predict success of weaning from intra-aortic balloon pumping. Am J Cardiol 2014.
11. Tokita Y, Yamamoto T, Sato N, Hosokawa Y, Munakata R, Akutsu K, Shimizu W, Tanaka K. Usefulness of N-terminal pro-brain natriuretic peptide levels to predict success of weaning from intra-aortic balloon pumping. Am J Cardiol 2014.
12. Greene SJ, Shah AN, Butler J, Ambrosy AP, Anker SD, Chioncel O, Collins SP, Dinh W, Dunnmon PM, Fonarow GC, Lam CSP, Mentz RJ, Pieske B, Roessig L, Rosano GMC, Sato N, Vaduganathan M, Gheorghiade M. Designing effective drug and device development programs for hospitalized heart failure: A proposal for pre-trial registries. Am Heart J 168: 142-149, 2014.
13. Kinugawa K, Sato N, Inomata T, Shimakawa T, Iwatake N, Mizuguchi K. Efficacy and Safety of Tolvaptan in Heart Failure Patients with Volume Overload - An Interim Result of Post Marketing Surveillance in Japan- Circ J 2014;78:844-852.
14. Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, Nodari S, Lam CS, Sato N, Shah AN, Gheorghiade M. The Global Health and Economic Burden of Hospitalizations for Heart Failure: Lessons Learned from HHF Registries. J Am Coll Cardiol. 2014; 63: 1123-1133.
15. Sotomi Y, Sato N, KajimotoK, Takano T. Impact of pulmonary artery catheter on outcome in patients with acute heart failure syndromes with hypotension or receiving inotropes: From the ATTEND registry. Int J Cardiol 172: 165-72, 2014.
16. Kajimoto K, Sato N, Keida T, Sakata Y, Asai K, Mizuno M, Takano T; investigators of the Acute Decompensated Heart Failure Syndromes (ATTEND) registry. Low admission heart rate is a marker rather than a mediator of increased in-hospital mortality for patients with acute heart failure syndromes in sinus rhythm. Int J Cardiol. 171:98-100, 2014.

武蔵小杉病院 循環器内科の実績はこちら